The Effect of COVID-19 on Diabetes Mellitus

• Conditions: Covid19; Diabetes Mellitus

• Registration Number: NCT04592055
• Lead Sponsor: Uşak University

Brief Summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Detailed Description

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Study Timeline

• Study Start: 2020-03-20
• Primary Completion: 2020-10-15
• Study First Submitted: 2020-10-16
• Study First Submitted QC: 2020-10-16
• Study First Posted: 2020-10-19
• Status Verified: 2021-05
• Last Update Submitted: 2021-05-01
• Last Update Posted: 2021-05-04
• Study Completion: 2021-07-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

Exclusion Criteria

• The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A1c	6 months (3 months before and after COVID-19	the change in A1c levels

Trial Locations

Locations (1)

Usak University Training and Research Hospital; 🇹🇷 Usak, Turkey